Summary
Updated Aug 31, 2026
Jeff Castelli is Chief Development Officer of AMICUS THERAPEUTICS, INC. (FOLD). 3 SEC Form 4 filings on record going back to 2025, most recently on 27 April 2026. Most recent open-market trade: sold $774K of FOLD on 26 November 2025. Lifetime open-market sales: $774K.
Recent Transactions
5Every recent SEC Form 4 transaction Jeff Castelli has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeff Castelli files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bradley L. Campbell - $2.53M of FOLD open-market activity in the last 12 months
- David Michael Clark - $1.15M of FOLD open-market activity in the last 12 months
- Ellen Rosenberg - $958K of FOLD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jeff Castelli?
Jeff Castelli is a corporate insider, tracked as Chief Development Officer of AMICUS THERAPEUTICS, INC. (FOLD). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jeff Castelli last file a Form 4?
The most recent primary Form 4 on record is dated 27 April 2026, one of 3 filings going back to 2025.
Has Jeff Castelli been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($774K) across all tracked filings.
Where can I see all of Jeff Castelli's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jeff Castelli and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
